BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Mair, Nina K
Petric, Philipp P
Wong, W Wei-Lynn
Hale, Benjamin G
MetadataShow full item record
AbstractInterferon (IFN) induction of IFN-stimulated genes (ISGs) creates a formidable protective antiviral state. However, loss of appropriate control mechanisms can result in constitutive pathogenic ISG upregulation. Here, we used genome-scale loss-of-function screening to establish genes critical for IFN-induced transcription, identifying all expected members of the JAK-STAT signaling pathway and a previously unappreciated epigenetic reader, bromodomain-containing protein 9 (BRD9), the defining subunit of non-canonical BAF (ncBAF) chromatin-remodeling complexes. Genetic knockout or small-molecule-mediated degradation of BRD9 limits IFN-induced expression of a subset of ISGs in multiple cell types and prevents IFN from exerting full antiviral activity against several RNA and DNA viruses, including influenza virus, human immunodeficiency virus (HIV1), and herpes simplex virus (HSV1). Mechanistically, BRD9 acts at the level of transcription, and its IFN-triggered proximal association with the ISG transcriptional activator, STAT2, suggests a functional localization at selected ISG promoters. Furthermore, BRD9 relies on its intact acetyl-binding bromodomain and unique ncBAF scaffolding interaction with GLTSCR1/1L to promote IFN action. Given its druggability, BRD9 is an attractive target for dampening ISG expression under certain autoinflammatory conditions.
CitationEMBO Rep. 2021 Aug 16:e52823. doi: 10.15252/embr.202152823. Epub ahead of print.
AffiliationHIRI, Helmholtz-Institut für RNA-basierte Infektionsforschung, Josef-Shneider Strasse 2, 97080 Würzburg, Germany.
The following license files are associated with this item:
- Creative Commons
- BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4.
- Authors: Ahmed NS, Gatchalian J, Ho J, Burns MJ, Hah N, Wei Z, Downes M, Evans RM, Hargreaves DC
- Issue date: 2022 Jan 4
- Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon.
- Authors: Mair NK, Hale BG
- Issue date: 2022 Sep 13
- A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
- Authors: Michalska A, Blaszczyk K, Wesoly J, Bluyssen HAR
- Issue date: 2018
- Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
- Authors: Wang W, Yin Y, Xu L, Su J, Huang F, Wang Y, Boor PPC, Chen K, Wang W, Cao W, Zhou X, Liu P, van der Laan LJW, Kwekkeboom J, Peppelenbosch MP, Pan Q
- Issue date: 2017 Apr 25
- BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.
- Authors: Alpsoy A, Utturkar SM, Carter BC, Dhiman A, Torregrosa-Allen SE, Currie MP, Elzey BD, Dykhuizen EC
- Issue date: 2021 Feb 15